Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q2 2022 Earnings Conference Call August 15, 2022 4:30 PM ET Company Participants Anna Marie Wagner – Senior Vice President-Corporate Development Jason Kelly – Co-Founder and Chief Executive Officer Mark Dmytruk – Chief Financial Officer Conference Call Participants Matt Sykes – Goldman Sachs Matt Larew – William Blair Tejas Savant – Morgan Stanley Steve Mah – Cowen Rahul Sarugaser – Raymond James Vivian Bais – BTIG Anna Marie Wagner Good afternoon. This is Anna Mari ...

Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Class A common stock, par value $0.0001 per share DNA NYSE Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share DNA.WS NYSE UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION ...

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q1 2022 Earnings Conference Call May 16, 2022 4:30 PM ET Company Participants Anna Marie Wagner - SVP of Corporate Development Jason Kelly - Co-Founder & CEO Mark Dmytruk - CFO Conference Call Participants Matt Sykes - Goldman Sachs Tejas Savant - Morgan Stanley Rahul Sarugaser - Raymond James Mark Massaro - BTIG Steve Mah - Cowen Derik De Bruin - Bank of America Anna Marie Wagner Good afternoon. This is Anna Marie Wagner, SVP of Corporate Development at Ginkgo Biow ...

Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Class A common stock, par value $0.0001 per share DNA NYSE Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share DNA.WS NYSE UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITIO ...

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2021 Earnings Conference Call March 28, 2022 4:30 PM ET CompanyParticipants Anna Marie Wagner - Senior Vice President of Corporate Development Jason Kelly - Co-Founder & Chief Executive Officer Mark Dmytruk - Chief Financial Officer Conference Call Participants Matt Larew - William Blair Tejas Savant - Morgan Stanley Rahul Sarugaser - Raymond James Mark Massaro - BTIG Steve Mah - Cowen Derik De Bruin - Bank of America Matt Sykes - Goldman Sachs Anna Marie Wagner ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40097 GINKGO BIOWORKS HOLDINGS, INC. (Exact name of Registrant as specified in its Charter) Delaware 87-2652913 (St ...

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q3 2021 Earnings Conference Call November 15, 2021 8:00 AM ET Company Participants Anna Marie Wagner - Senior Vice President of Corporate Development Jason Kelly - Co-Founder and Chief Executive Officer Mark Dmytruk - Chief Financial Officer Conference Call Participants Matthew Larew - William Blair & Company LLC Rahul Sarugaser - Raymond James Ltd. Harsha Pappu - HSBC Anna Marie Wagner Good morning, everyone. This is Anna Marie Wagner. I'm the SVP of Corporate Deve ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Class A common stock, par value $0.0001 per share DNA NYSE Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share DNA.WS NYSE FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSU ...

Table of Contents Title of each classTrading Symbol(s)Name of each exchange on which registered Units, each consisting of one Class A ordinary share and one-fifth of one redeemable warrant SRNGU The Nasdaq Stock Market LLC Class A ordinary shares, par value $0.0001 per share SRNG The Nasdaq Stock Market LLC Warrants, each whole warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share SRNGW The Nasdaq Stock Market LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION W ...

Call Start: 16:30 January 1, 0000 5:13 PM ET Zymergen, Inc. (ZY) Q1 2021 Earnings Conference Call May 24, 2021, 16:30 PM ET[Indiscernible] Company Participants Niraj Javeri - IR Josh Hoffman - Co-Founder and Chief Executive Officer Enakshi Singh - Chief Financial Officer Conference Call Participants Doug Schenkel - Cowen Tycho Peterson - JP Morgan Matt Sykes - Goldman Sachs Dan Brennan - UBS Operator Good day and thank you for standing by. Welcome to the Zymergen First Quarter 2021 Financial Results Confer ...